Home > Smoking Cessation
Smoking Cessation
Welcome to the smoking cessation category for physicians and pharmacists. This clinical category includes links to resources on smoking cessation guidelines, drug interactions in smokers and prescribing nicotine replacement therapy (NRT), bupropion and varenicline.
The Cochrane Collaboration
Cochrane Reviews - Tobacco
The Cochrane Collaboration is an international, non-profit, independent organisation, established to ensure that up-to-date, accurate information about the effects of healthcare interventions is readily available worldwide. It produces and disseminates systematic reviews of healthcare interventions, and promotes the search for evidence in the form of clinical trials and other studies of the effects of interventions.
Source: cochrane.org |
Clinical Resource: Systematic Reviews |
Register to Access Content: No |
ASH provides guidance on the latest developments and evidence to help people stop smoking.
Smoking Reduction
Smoking Cessation Services
NRT or Nicotine Replacement Therapies
Varenicline or Champix
Buproprion or Zyban
Source: ash.org.uk |
Clinical Resource: Various |
Register to Access Content: No |
Smoking Cessation
This bulletin will look at the different forms of nicotine replacement products available, their effectiveness and safety. Their use in specific patient groups will also be discussed. Bupropion, will also be reviewed.
Source: stjames.ie |
Clinical Resource: Medicines Information Centre Bulletin |
Register to Access Content: No |
Smokefree Pharmacotherapy
This table compares the drug treatments that are available to support patients with their quit attempts
Source: saferx.co.nz |
Clinical Resource: Table |
Register to Access Content: No |
Drug Interactions with Tobacco Smoke
Many interactions between tobacco smoke and medications have been identified. Note that in most cases it is the tobacco smoke—not the nicotine—that causes these drug interactions. Tobacco smoke interacts with medications through pharmacokinetic (PK) and pharmacodynamic (PD) mechanisms. PK interactions affect the
absorption, distribution, metabolism, or elimination of other drugs, potentially causing an altered pharmacologic response.
Source: smokingcessationleadership.ucsf.edu |
Clinical Resource: Table |
Register to Access Content: No |
Potential drug interactions with smoking and quitting
Chart of the most common drug interaction issues connected to the use of tobacco
Source: health.gov.bc.ca |
Clinical Resource: Chart |
Register to Access Content: No |
|